Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Statin use and risk of recurrent venous thrombosis: results from the MEGA follow-up study.

Research and practice in thrombosis and haemostasis

Brækkan SK, Caram-Deelder C, Siegerink B, van Hylckama Vlieg A, le Cessie S, Rosendaal FR, Cannegieter SC, Lijfering WM.
PMID: 30046679
Res Pract Thromb Haemost. 2017 May 25;1(1):112-119. doi: 10.1002/rth2.12003. eCollection 2017 Jul.

INTRODUCTION: Whether statin use after first venous thrombosis reduces the risk of recurrence is uncertain. Therefore, we aimed to examine the risk of recurrent venous thrombosis in statin users vs non-users.METHODS: Patients with a first venous thrombosis were recruited...

Cite
Brækkan SK, Caram-Deelder C, Siegerink B, et al. Statin use and risk of recurrent venous thrombosis: results from the MEGA follow-up study. Res Pract Thromb Haemost. 2017;1(1):112-119doi: 10.1002/rth2.12003.
Brækkan, S. K., Caram-Deelder, C., Siegerink, B., van Hylckama Vlieg, A., le Cessie, S., Rosendaal, F. R., Cannegieter, S. C., & Lijfering, W. M. (2017). Statin use and risk of recurrent venous thrombosis: results from the MEGA follow-up study. Research and practice in thrombosis and haemostasis, 1(1), 112-119. https://doi.org/10.1002/rth2.12003
Brækkan, Sigrid K, et al. "Statin use and risk of recurrent venous thrombosis: results from the MEGA follow-up study." Research and practice in thrombosis and haemostasis vol. 1,1 (2017): 112-119. doi: https://doi.org/10.1002/rth2.12003
Brækkan SK, Caram-Deelder C, Siegerink B, van Hylckama Vlieg A, le Cessie S, Rosendaal FR, Cannegieter SC, Lijfering WM. Statin use and risk of recurrent venous thrombosis: results from the MEGA follow-up study. Res Pract Thromb Haemost. 2017 May 25;1(1):112-119. doi: 10.1002/rth2.12003. eCollection 2017 Jul. PMID: 30046679; PMCID: PMC6058203.
Copy Download .nbib Format: NLM
Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation.

Blood

Goumidi L, Thibord F, Wiggins KL, Li-Gao R, Brown MR, van Hylckama Vlieg A, Souto JC, Soria JM, Ibrahim-Kosta M, Saut N, Daian D, Olaso R, Amouyel P, Debette S, Boland A, Bailly P, Morrison AC, Mook-Kanamori DO, Deleuze JF, Johnson A, de Vries PS, Sabater-Lleal M, Chiaroni J, Smith NL, Rosendaal FR, Chasman DI, Trégouët DA, Morange PE.
PMID: 33512453
Blood. 2021 Apr 29;137(17):2394-2402. doi: 10.1182/blood.2020008997.

Genetic risk score (GRS) analysis is a popular approach to derive individual risk prediction models for complex diseases. In venous thrombosis (VT), such type of analysis shall integrate information at the ABO blood group locus, which is one of...

Cite
Goumidi L, Thibord F, Wiggins KL, et al. Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation. Blood. 2021;137(17):2394-2402doi: 10.1182/blood.2020008997.
Goumidi, L., Thibord, F., Wiggins, K. L., Li-Gao, R., Brown, M. R., van Hylckama Vlieg, A., Souto, J. C., Soria, J. M., Ibrahim-Kosta, M., Saut, N., Daian, D., Olaso, R., Amouyel, P., Debette, S., Boland, A., Bailly, P., Morrison, A. C., Mook-Kanamori, D. O., Deleuze, J. F., Johnson, A., de Vries, P. S., Sabater-Lleal, M., Chiaroni, J., Smith, N. L., Rosendaal, F. R., Chasman, D. I., Trégouët, D. A., & Morange, P. E. (2021). Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation. Blood, 137(17), 2394-2402. https://doi.org/10.1182/blood.2020008997
Goumidi, Louisa, et al. "Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation." Blood vol. 137,17 (2021): 2394-2402. doi: https://doi.org/10.1182/blood.2020008997
Goumidi L, Thibord F, Wiggins KL, Li-Gao R, Brown MR, van Hylckama Vlieg A, Souto JC, Soria JM, Ibrahim-Kosta M, Saut N, Daian D, Olaso R, Amouyel P, Debette S, Boland A, Bailly P, Morrison AC, Mook-Kanamori DO, Deleuze JF, Johnson A, de Vries PS, Sabater-Lleal M, Chiaroni J, Smith NL, Rosendaal FR, Chasman DI, Trégouët DA, Morange PE. Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation. Blood. 2021 Apr 29;137(17):2394-2402. doi: 10.1182/blood.2020008997. PMID: 33512453; PMCID: PMC8085481.
Copy Download .nbib Format: NLM
Combined hormonal contraceptive use in Europe before and after the European Commission mandated changes in product information.

Contraception: X

Khialani D, Jones ME, Szépligeti SK, Ording AG, Ehrenstein V, Petersen I, van Hylckama Vlieg A.
PMID: 32550533
Contracept X. 2020 Jan 14;2:100018. doi: 10.1016/j.conx.2020.100018. eCollection 2020.

OBJECTIVES: We investigated combined hormonal contraceptives (CHC) prescribing patterns (focusing on combined oral contraceptives; COC) in three countries (Netherlands, Denmark, United Kingdom) in a time period preceding and in a time period following the European Commission's decision to update...

Cite
Khialani D, Jones ME, Szépligeti SK, et al. Combined hormonal contraceptive use in Europe before and after the European Commission mandated changes in product information. Contracept X. 2020;2:100018doi: 10.1016/j.conx.2020.100018.
Khialani, D., Jones, M. E., Szépligeti, S. K., Ording, A. G., Ehrenstein, V., Petersen, I., & van Hylckama Vlieg, A. (2020). Combined hormonal contraceptive use in Europe before and after the European Commission mandated changes in product information. Contraception: X, 2100018. https://doi.org/10.1016/j.conx.2020.100018
Khialani, Deeksha, et al. "Combined hormonal contraceptive use in Europe before and after the European Commission mandated changes in product information." Contraception: X vol. 2 (2020): 100018. doi: https://doi.org/10.1016/j.conx.2020.100018
Khialani D, Jones ME, Szépligeti SK, Ording AG, Ehrenstein V, Petersen I, van Hylckama Vlieg A. Combined hormonal contraceptive use in Europe before and after the European Commission mandated changes in product information. Contracept X. 2020 Jan 14;2:100018. doi: 10.1016/j.conx.2020.100018. eCollection 2020. PMID: 32550533; PMCID: PMC7286180.
Copy Download .nbib Format: NLM
[No title available]

Huisarts en wetenschap

van Hylckama Vlieg A, Rosendaal F, Mook-Kanamori D.
PMID: 32292209
Huisarts Wet. 2020 Apr 11;1-2. doi: 10.1007/s12445-020-0586-9. Epub 2020 Apr 11.

No abstract available.

Cite
van Hylckama Vlieg A, Rosendaal F, Mook-Kanamori D. FFP2-mondmasker of chirurgisch mondkapje bij COVID-19. . Huisarts Wet. 2020;1-2doi: 10.1007/s12445-020-0586-9.
van Hylckama Vlieg, A., Rosendaal, F., & Mook-Kanamori, D. (2020). FFP2-mondmasker of chirurgisch mondkapje bij COVID-19. . Huisarts en wetenschap, 1-2. https://doi.org/10.1007/s12445-020-0586-9
van Hylckama Vlieg, Astrid, et al. "FFP2-mondmasker of chirurgisch mondkapje bij COVID-19." . Huisarts en wetenschap vol. (2020): 1-2. doi: https://doi.org/10.1007/s12445-020-0586-9
van Hylckama Vlieg A, Rosendaal F, Mook-Kanamori D. FFP2-mondmasker of chirurgisch mondkapje bij COVID-19. . Huisarts Wet. 2020 Apr 11;1-2. doi: 10.1007/s12445-020-0586-9. Epub 2020 Apr 11. Dutch. PMID: 32292209; PMCID: PMC7150533.
Copy Download .nbib Format: NLM
Correction to: Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study.

Human genetics

Lindström S, Germain M, Crous-Bou M, Smith EN, Morange PE, van Hylckama Vlieg A, de Haan HG, Chasman D, Ridker P, Brody J, de Andrade M, Heit JA, Tang W, De Vivo I, Grodstein F, Smith NL, Tregouet D, Kabrhel C.
PMID: 29779052
Hum Genet. 2018 May;137(5):429. doi: 10.1007/s00439-018-1891-2.

The co-author name Immaculata DeVivo was incorrectly published. The correct name is given below.

Cite
Lindström S, Germain M, Crous-Bou M, et al. Correction to: Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study. Hum Genet. 2018;137(5):429doi: 10.1007/s00439-018-1891-2.
Lindström, S., Germain, M., Crous-Bou, M., Smith, E. N., Morange, P. E., van Hylckama Vlieg, A., de Haan, H. G., Chasman, D., Ridker, P., Brody, J., de Andrade, M., Heit, J. A., Tang, W., De Vivo, I., Grodstein, F., Smith, N. L., Tregouet, D., Kabrhel, C. (2018). Correction to: Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study. Human genetics, 137(5), 429. https://doi.org/10.1007/s00439-018-1891-2
Lindström, Sara, et al. "Correction to: Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study." Human genetics vol. 137,5 (2018): 429. doi: https://doi.org/10.1007/s00439-018-1891-2
Lindström S, Germain M, Crous-Bou M, Smith EN, Morange PE, van Hylckama Vlieg A, de Haan HG, Chasman D, Ridker P, Brody J, de Andrade M, Heit JA, Tang W, De Vivo I, Grodstein F, Smith NL, Tregouet D, Kabrhel C. Correction to: Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study. Hum Genet. 2018 May;137(5):429. doi: 10.1007/s00439-018-1891-2. PMID: 29779052.
Copy Download .nbib Format: NLM
Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).

PLoS medicine

Timp JF, Braekkan SK, Lijfering WM, van Hylckama Vlieg A, Hansen JB, Rosendaal FR, le Cessie S, Cannegieter SC.
PMID: 33891592
PLoS Med. 2021 Apr 23;18(4):e1003612. doi: 10.1371/journal.pmed.1003612. eCollection 2021 Apr.

[This corrects the article DOI: 10.1371/journal.pmed.1002883.].

Cite
Timp JF, Braekkan SK, Lijfering WM, et al. Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP). PLoS Med. 2021;18(4):e1003612doi: 10.1371/journal.pmed.1003612.
Timp, J. F., Braekkan, S. K., Lijfering, W. M., van Hylckama Vlieg, A., Hansen, J. B., Rosendaal, F. R., le Cessie, S., & Cannegieter, S. C. (2021). Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP). PLoS medicine, 18(4), e1003612. https://doi.org/10.1371/journal.pmed.1003612
Timp, Jasmijn F, et al. "Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)." PLoS medicine vol. 18,4 (2021): e1003612. doi: https://doi.org/10.1371/journal.pmed.1003612
Timp JF, Braekkan SK, Lijfering WM, van Hylckama Vlieg A, Hansen JB, Rosendaal FR, le Cessie S, Cannegieter SC. Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP). PLoS Med. 2021 Apr 23;18(4):e1003612. doi: 10.1371/journal.pmed.1003612. eCollection 2021 Apr. PMID: 33891592; PMCID: PMC8064740.
Copy Download .nbib Format: NLM
A Workflow for Missing Values Imputation of Untargeted Metabolomics Data.

Metabolites

Faquih T, van Smeden M, Luo J, le Cessie S, Kastenmüller G, Krumsiek J, Noordam R, van Heemst D, Rosendaal FR, van Hylckama Vlieg A, Willems van Dijk K, Mook-Kanamori DO.
PMID: 33256233
Metabolites. 2020 Nov 26;10(12). doi: 10.3390/metabo10120486.

Metabolomics studies have seen a steady growth due to the development and implementation of affordable and high-quality metabolomics platforms. In large metabolite panels, measurement values are frequently missing and, if neglected or sub-optimally imputed, can cause biased study results....

Cite
Faquih T, van Smeden M, Luo J, et al. A Workflow for Missing Values Imputation of Untargeted Metabolomics Data. Metabolites. 2020;10(12)doi: 10.3390/metabo10120486.
Faquih, T., van Smeden, M., Luo, J., le Cessie, S., Kastenmüller, G., Krumsiek, J., Noordam, R., van Heemst, D., Rosendaal, F. R., van Hylckama Vlieg, A., Willems van Dijk, K., & Mook-Kanamori, D. O. (2020). A Workflow for Missing Values Imputation of Untargeted Metabolomics Data. Metabolites, 10(12), . https://doi.org/10.3390/metabo10120486
Faquih, Tariq, et al. "A Workflow for Missing Values Imputation of Untargeted Metabolomics Data." Metabolites vol. 10,12 (2020). doi: https://doi.org/10.3390/metabo10120486
Faquih T, van Smeden M, Luo J, le Cessie S, Kastenmüller G, Krumsiek J, Noordam R, van Heemst D, Rosendaal FR, van Hylckama Vlieg A, Willems van Dijk K, Mook-Kanamori DO. A Workflow for Missing Values Imputation of Untargeted Metabolomics Data. Metabolites. 2020 Nov 26;10(12). doi: 10.3390/metabo10120486. PMID: 33256233; PMCID: PMC7761057.
Copy Download .nbib Format: NLM
Postprandial metabolite profiles associated with type 2 diabetes clearly stratify individuals with impaired fasting glucose.

Metabolomics : Official journal of the Metabolomic Society

Li-Gao R, de Mutsert R, Rensen PCN, van Klinken JB, Prehn C, Adamski J, van Hylckama Vlieg A, den Heijer M, le Cessie S, Rosendaal FR, Willems van Dijk K, Mook-Kanamori DO.
PMID: 29249917
Metabolomics. 2018;14(1):13. doi: 10.1007/s11306-017-1307-7. Epub 2017 Dec 12.

INTRODUCTION: Fasting metabolite profiles have been shown to distinguish type 2 diabetes (T2D) patients from normal glucose tolerance (NGT) individuals.OBJECTIVES: We investigated whether, besides fasting metabolite profiles, postprandial metabolite profiles associated with T2D can stratify individuals with impaired fasting...

Cite
Li-Gao R, de Mutsert R, Rensen PCN, et al. Postprandial metabolite profiles associated with type 2 diabetes clearly stratify individuals with impaired fasting glucose. Metabolomics. 2017;14(1):13doi: 10.1007/s11306-017-1307-7.
Li-Gao, R., de Mutsert, R., Rensen, P. C. N., van Klinken, J. B., Prehn, C., Adamski, J., van Hylckama Vlieg, A., den Heijer, M., le Cessie, S., Rosendaal, F. R., Willems van Dijk, K., & Mook-Kanamori, D. O. (2018). Postprandial metabolite profiles associated with type 2 diabetes clearly stratify individuals with impaired fasting glucose. Metabolomics : Official journal of the Metabolomic Society, 14(1), 13. https://doi.org/10.1007/s11306-017-1307-7
Li-Gao, Ruifang, et al. "Postprandial metabolite profiles associated with type 2 diabetes clearly stratify individuals with impaired fasting glucose." Metabolomics : Official journal of the Metabolomic Society vol. 14,1 (2018): 13. doi: https://doi.org/10.1007/s11306-017-1307-7
Li-Gao R, de Mutsert R, Rensen PCN, van Klinken JB, Prehn C, Adamski J, van Hylckama Vlieg A, den Heijer M, le Cessie S, Rosendaal FR, Willems van Dijk K, Mook-Kanamori DO. Postprandial metabolite profiles associated with type 2 diabetes clearly stratify individuals with impaired fasting glucose. Metabolomics. 2018;14(1):13. doi: 10.1007/s11306-017-1307-7. Epub 2017 Dec 12. PMID: 29249917; PMCID: PMC5727148.
Copy Download .nbib Format: NLM
[Mendelian randomisation].

Nederlands tijdschrift voor geneeskunde

de Haan HG, Siegerink B, van Hylckama Vlieg A.
PMID: 25322353
Ned Tijdschr Geneeskd. 2014;158:A7547.

Classical observational studies into the causal relationship between a risk factor and a disease sometimes result in contradictory and spurious findings. This is due to confounding factors. It is not possible to conclude from the results of classical observational...

Cite
de Haan HG, Siegerink B, van Hylckama Vlieg A. Mendeliaanse randomisatie. [Mendelian randomisation]. Ned Tijdschr Geneeskd. 2014;158:A7547
de Haan, H. G., Siegerink, B., & van Hylckama Vlieg, A. (2014). Mendeliaanse randomisatie. [Mendelian randomisation]. Nederlands tijdschrift voor geneeskunde, 158A7547.
de Haan, Hugoline G, et al. "Mendeliaanse randomisatie." [Mendelian randomisation]. Nederlands tijdschrift voor geneeskunde vol. 158 (2014): A7547.
de Haan HG, Siegerink B, van Hylckama Vlieg A. Mendeliaanse randomisatie. [Mendelian randomisation]. Ned Tijdschr Geneeskd. 2014;158:A7547. Dutch. PMID: 25322353.
Copy Download .nbib Format: NLM
Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers.

Research and practice in thrombosis and haemostasis

Faquih T, Mook-Kanamori DO, Rosendaal FR, Baglin T, Willems van Dijk K, van Hylckama Vlieg A.
PMID: 34013156
Res Pract Thromb Haemost. 2021 May 04;5(4):e12526. doi: 10.1002/rth2.12526. eCollection 2021 May.

BACKGROUND: Venous thromboembolism (VTE) is a complex disease with an incidence rate of about 1 in 1000 per year. Despite the availability of validated biomarkers for VTE, unprovoked events account for 50% of first events. Therefore, emerging high-throughput proteomics...

Cite
Faquih T, Mook-Kanamori DO, Rosendaal FR, et al. Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers. Res Pract Thromb Haemost. 2021;5(4):e12526doi: 10.1002/rth2.12526.
Faquih, T., Mook-Kanamori, D. O., Rosendaal, F. R., Baglin, T., Willems van Dijk, K., & van Hylckama Vlieg, A. (2021). Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers. Research and practice in thrombosis and haemostasis, 5(4), e12526. https://doi.org/10.1002/rth2.12526
Faquih, Tariq, et al. "Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers." Research and practice in thrombosis and haemostasis vol. 5,4 (2021): e12526. doi: https://doi.org/10.1002/rth2.12526
Faquih T, Mook-Kanamori DO, Rosendaal FR, Baglin T, Willems van Dijk K, van Hylckama Vlieg A. Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers. Res Pract Thromb Haemost. 2021 May 04;5(4):e12526. doi: 10.1002/rth2.12526. eCollection 2021 May. PMID: 34013156; PMCID: PMC8110437.
Copy Download .nbib Format: NLM
Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice.

Frontiers in microbiology

Martín R, Laval L, Chain F, Miquel S, Natividad J, Cherbuy C, Sokol H, Verdu EF, van Hylckama Vlieg J, Bermudez-Humaran LG, Smokvina T, Langella P.
PMID: 27199937
Front Microbiol. 2016 May 06;7:608. doi: 10.3389/fmicb.2016.00608. eCollection 2016.

Growing evidence supports the efficacy of many probiotic strains in the management of gastrointestinal disorders associated with deregulated intestinal barrier function and/or structure. In particular, bifidobacteria have been studied for their efficacy to both prevent and treat a broad...

Cite
Martín R, Laval L, Chain F, et al. Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice. Front Microbiol. 2016;7:608doi: 10.3389/fmicb.2016.00608.
Martín, R., Laval, L., Chain, F., Miquel, S., Natividad, J., Cherbuy, C., Sokol, H., Verdu, E. F., van Hylckama Vlieg, J., Bermudez-Humaran, L. G., Smokvina, T., & Langella, P. (2016). Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice. Frontiers in microbiology, 7608. https://doi.org/10.3389/fmicb.2016.00608
Martín, Rebeca, et al. "Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice." Frontiers in microbiology vol. 7 (2016): 608. doi: https://doi.org/10.3389/fmicb.2016.00608
Martín R, Laval L, Chain F, Miquel S, Natividad J, Cherbuy C, Sokol H, Verdu EF, van Hylckama Vlieg J, Bermudez-Humaran LG, Smokvina T, Langella P. Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice. Front Microbiol. 2016 May 06;7:608. doi: 10.3389/fmicb.2016.00608. eCollection 2016. PMID: 27199937; PMCID: PMC4858658.
Copy Download .nbib Format: NLM
D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly.

Research and practice in thrombosis and haemostasis

Wang H, Rosendaal FR, Cushman M, van Hylckama Vlieg A.
PMID: 34263100
Res Pract Thromb Haemost. 2021 Jun 21;5(5):e12536. doi: 10.1002/rth2.12536. eCollection 2021 Jul.

BACKGROUND: A high D-dimer level and parameters of the thrombin generation (TG) potential are associated with the risk of a first venous thrombosis (VT) in young and middle-aged populations.OBJECTIVES: To investigate whether D-dimer and TG potential (lag-time, time-to-peak [ttPeak],...

Cite
Wang H, Rosendaal FR, Cushman M, et al. D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly. Res Pract Thromb Haemost. 2021;5(5):e12536doi: 10.1002/rth2.12536.
Wang, H., Rosendaal, F. R., Cushman, M., & van Hylckama Vlieg, A. (2021). D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly. Research and practice in thrombosis and haemostasis, 5(5), e12536. https://doi.org/10.1002/rth2.12536
Wang, Huijie, et al. "D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly." Research and practice in thrombosis and haemostasis vol. 5,5 (2021): e12536. doi: https://doi.org/10.1002/rth2.12536
Wang H, Rosendaal FR, Cushman M, van Hylckama Vlieg A. D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly. Res Pract Thromb Haemost. 2021 Jun 21;5(5):e12536. doi: 10.1002/rth2.12536. eCollection 2021 Jul. PMID: 34263100; PMCID: PMC8268666.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries